December 08, 2021

TELES Aktiengesellschaft Informationstechnologien: Management carries out a capital increase from authorized capital against contribution in kind

Berlin (08.12.2021/21:30) – At the general meeting of TELES Aktiengesellschaft Informationstechnologien ("Company") on August 8, 2017, the management board was authorized, with the consent of the company's supervisory board, to increase the share capital by December 31, 2021 by a total of up to EUR 11,652,338.00 through one or multiple issuance of up to 11,652,338 new no-par value bearer shares against cash and / or contributions in kind (Authorized Capital 2017 / I).

The company's management board, with the approval of the supervisory board, decided on a capital increase based on the authorized capital in accordance with the articles of association, partially utilizing the authorized capital 2017 / I. The company's share capital was increased by EUR 1,863,792.00 to EUR 6,233,418.00. 1,863,792 no-par value bearer shares were issued at an issue price of EUR 1.00 per share with entitlement to profit from January 1, 2022. The capital increase took place against a contribution in kind.

With the entry of the capital increase in kind in the commercial register, the takeover of the majority of the Europe-wide pharmaceutical supplier EURO RX Arzneimittel GmbH was successfully completed today.

The Management Board


Important instructions

This publication constitutes neither an offer to sell nor a solicitation to buy securities.

This announcement may not be published, distributed or transmitted in the United States of America, Australia, Japan or Canada. This release does not constitute an offer to purchase securities or a solicitation of an offer to purchase securities of TELES AG Informationstechnologien (the 'Shares') in the United States, Germany or other states. Shares may be registered in the United States only after prior registration or without prior registration only due to derogation from the registration requirement under the U.S. Securities Act of 1933 in the currently valid version (the 'Securities Act') are sold or offered for sale. The shares are not and will not be registered under the Securities Act.